Readily available biomarkers can help to identify patients with worst prognosis in metastatic pancreatic cancer

Authors :: L.G.M. van der Geest
N. Haj Mohammad
J. E. van Hooft
Johanna W. Wilmink
Marin Strijker
V.E.P.P. Lemmens
Marjolein Y.V. Homs
E. van Veldhuisen
O.R.C. Busch
J. de Vos-Geelen
H.W.M. van Laarhoven
J. Verheij
M.G. Besselink
Source :: HPB. 22:S327-S328
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Hepatology
business.industry
Internal medicine
Metastatic pancreatic cancer
Gastroenterology
Medicine
business

Tools